Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958347 · ClinicalTrials.gov registry record · NA
Omnifit Hydroxylapatite (HA) Hip Outcomes Study
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT00958347 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 226 participants.
The verdict
NCT00958347, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
The purpose of this study was to obtain up to 25 year post-operative data on the Omnifit Hydroxylapatite (HA) Hip System in support of the hypothesis that it is a satisfactory system for reducing implant loosening, permitting tissue bonding onto the hydroxylapatite surfaces of the implant and providing a safe, efficient, and well-functioning hip in a wide spectrum of clinical circumstances.
Interventions
- DEVICE Omnifit HA Hip Stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 1987-10 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00958347
The ClinicalTrials.gov registry entry for NCT00958347 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omnifit HA Hip Stem is the first listed.
NCT00958347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00958347 about?
NCT00958347 is a clinical study titled "Omnifit Hydroxylapatite (HA) Hip Outcomes Study". The purpose of this study was to obtain up to 25 year post-operative data on the Omnifit Hydroxylapatite (HA) Hip System in support of the hypothesis that it is a satisfactory system for reducing implant loosening, permitting tissue bonding onto the hydroxylapatite surfaces of the implant and provid...
What is the current status of trial NCT00958347?
This trial is currently terminated. It is a NA study. The enrollment target is 226 participants. The study started on 1987-10. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00958347?
The interventions under investigation include: Omnifit HA Hip Stem (DEVICE).
Who is sponsoring clinical trial NCT00958347?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.